SBC Medical Group Holdings Incorporated

SBC Industrials Consulting Services

SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.4%, EPS grew 400.0%, free cash flow grew 396.1% and total debt rose 420.7%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

5.16 0.14 −2.64%
Market cap
$545.1M
P/E
11.0×
Fwd P/E
6.6×
Dividend yield
—
F-score
3/9
Altman Z
4.74
Beneish M
−1.96
Dividend safety
n/a

Insider Decisions trades per month

Total sells 20.15
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — 1 2 — — — — — —
Insider Ownership 81.51%

Capital & Financial Ratios $m

Market Cap 545.09
Revenue 175.17
Net Income 49.60
Free Cash Flow 66.45
Net Debt (146.79)
Current Ratio 3.31 (at or above 1.5: strong)
Debt/Equity 0.14 (at or below 0.5: strong)
P/E ratio 10.98
Fwd P/E 6.62
P/S ratio 3.02
P/B ratio 1.89
Past 5Y EPS Growth —
This Y EPS Growth (8.27%) (below 0%: weak)
Next Y EPS Growth 13.93%
Next Y revenue growth 10.02% (at or above 10%: strong)
Next 5Y EPS Growth 1.43%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 40.45%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 103 125 164 185
Receivables 44 41 40 51
Inventory 3 1 3 3
Other 6 6 13 14
166 184 231 259
2023 2024 2025 Q'26
Payables 27 15 18 24
ST’ Debt 0 0 9 12
Other 25 13 7 5
92 61 61 78

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — — 0.00%
Earnings — — 351.81%
Book Value — — 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 43 49 — — —
’25 47 43 43 40 174
’24 55 53 53 44 205
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 9 23 — — —
’25 2 (8) (21) 52 25
’24 4 19 5 (7) 21
’23 0 (1) 24 28 51
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 9 22 — — —
’25 1 (7) (20) 56 30
’24 3 18 4 (8) 17
’23 0 (1) 28 21 48
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.11 0.10 — — —
’25 0.21 0.02 0.12 0.14 0.50
’24 0.20 0.20 0.03 0.06 0.48
’23 0.21 0.16 0.09 (0.05) 0.41
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — — 9.95 10.15 5.21 2.62

Analyst estimates 2026–2028

Powerpack
High — — — — — — 10.61 11.56 36.52 7.00
People
People Employees — — — — — — 2 2 863 863
Revenue/emp, $m — — — — — — 0.00 96.77 0.24 0.20
Income, $m
Income, $m Revenue — — — — — — — 194 205 174
Gross margin, % — — — — — — — 70.94 75.97 73.32
EBT — — — — — — 1 74 73 82
EBT margin, % — — — — — — 0.00 38.02 35.76 47.27
Net income — — — — — — 1 39 47 51
Depreciation — — — — — — — 12 4 3
Per share, $
Per share, $ Revenue — — — — — — 0.00 2.05 2.13 1.69
Earnings — — — — — — 0.16 0.41 0.48 0.50
Cash flow — — — — — — (0.17) 0.54 0.21 0.24
Capex — — — — — — 0.00 (0.03) (0.04) 0.05
Free cash flow — — — — — — (0.17) 0.50 0.18 0.29
Book value — — — — — — (1.25) 1.53 2.02 2.56
Shares, m — — — — — — 3 94 97 103
Valuation, ×
Valuation, × P/E — — — — — — — 26.38 11.44 8.80
P/S — — — — — — — 0.00 2.61 2.56
P/B — — — — — — — 7.07 2.75 1.69
EV/Sales — — — — — — — 0.00 2.04 1.86
EV/FCF — — — — — — — 18.30 24.36 10.84
Cash, $m
Cash, $m Operating cash flow — — — — — — 0 51 21 25
Capex — — — — — — — (3) (3) 5
Free cash flow — — — — — — 0 48 17 30
Balance, $m
Balance, $m Working capital — — — — — — 0 73 123 170
Total debt — — — — — — — 13 7 43
Net debt — — — — — — 0 (90) (118) (121)
Shareholders’ equity — — — — — — (3) 144 195 263
Returns, %
Returns, % ROA — — — — — — 0.00 20.79 17.76 15.77
ROIC — — — — — — 0.00 81.85 57.38 29.67
ROE — — — — — — 0.00 56.06 27.51 22.25
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

SBC Medical Group Holdings Incorporated vs peers in Consulting Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HURN Huron Consulting Group Inc. $2.8B 25.6× 14.7× +15.37% (above 0%: growing) +72.32% (above 0%: growing) +51.61% (above 0%: growing) 32.51% 10.58% Compare
ICFI ICF International, Inc. $1.6B 18.4× 11.7× −0.35% (below 0%: shrinking) +16.28% (above 0%: growing) +103.49% (above 0%: growing) 37.23% 8.41% Compare
CRAI Charles River Associates $1.1B 23.5× 17.6× +12.81% (above 0%: growing) +17.68% (above 0%: growing) −230.17% (below 0%: shrinking) 29.45% 11.17% Compare
SBC SBC Medical Group Holdings Incorporated $545.1M 11.0× 6.6× +13.44% (above 0%: growing) +400.00% (above 0%: growing) +396.07% (above 0%: growing) 73.14% 38.55%
ROMA Roma Green Finance Limited $496.8M — — — — +20.80% (above 0%: growing) — — Compare
FORR Forrester Research, Inc. $227.2M — (loss-making) — (loss-making) −10.23% (below 0%: shrinking) +276.19% (above 0%: growing) −197.82% (below 0%: shrinking) 56.38% 3.39% Compare
LAWR Robot Consulting Co., Ltd. $172.4M — — — — −270.95% (below 0%: shrinking) — — Compare
EGG Enigmatig Limited $131.9M — — — — — — — Compare
RGP Resources Connection, Inc. $94.4M — (loss-making) — (loss-making) −18.42% (below 0%: shrinking) n/m −140.54% (below 0%: shrinking) 37.38% (7.45%) Compare
Median of peers $362.0M 23.5× 14.7× −0.35% +45.00% −140.54% 37.23% 8.41%

All 23 Consulting Services stocks →

SBC Medical Group Holdings Incorporated (SBC) key facts

  • Concern: SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024.
  • SBC Medical Group Holdings Incorporated (SBC) is a Consulting Services company in the Industrials sector, listed on Nasdaq.
  • As of October 16, 2026, SBC traded at $5.16, a market capitalization of $545.1 million.
  • Return on equity was 22.3% and debt-to-equity 0.14.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 4.74 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

SBC Medical Group Holdings Incorporated (SBC) Latest News

13 Aug

Impact 4 · transcript
stockrow.com/SBC · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com